Skip to content

Evaluation of BIomarkers for POstoperative Complications in Non-cardiac Surgery Patients

Evaluation of hsTnT for Perioperative Risk Stratification Among Patients Undergoing Elective Non-cardiac Surgery

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03765372
Enrollment
1598
Registered
2018-12-05
Start date
2017-06-19
Completion date
2021-12-18
Last updated
2024-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Outcome, Perioperative/Postoperative Complications

Keywords

perioperative outcome, clavien-dindo classification, hsTnT, MINS

Brief summary

Aim of this study is to evaluate whether the periopertive course is able to predict postoperative complications. Several approaches will be choosed to optimize perioperative risk stratification predicting postoperative complications in patients undergoing elective non-cardiac surgery.

Detailed description

The aim of this secondary analysis of the SUPERADD study is to use the perioperative data from the prospective SUPERADD study (SUbstitution of PERioperative Albumin Deficiency Disorders) (Eudra-CT 2016-001313-24; Clinical Trials NCT03167645; DOI: 10.1097) to identify risk factors for the occurrence of postoperative complications, based on the Clavien-Dindo classification in the nine domains of the Postoperative Morbidity Survey. Multivariate Analyses, Decision trees, time series analysis and Machine Learning methods will be applied to distinguish risk factors for postoperative complikations and mortality in a high-risk group (see publication of the statistical analysis plan and its enhancement). Patients participating in the SUPERADD study (NCT03167656) and who had at least two perioperative high sensitive Troponin T (hsTnT) values in order to detect myocardial injury were included in this secondary analysis as hsTnT is associated with major adverse cardiovascular events (MACE), myocardial injury after noncardiac surgery and mortality. The secondary analysis uses data obtained at the pre-anaesthesia visit like ASA, preoperative comorbidities measured by the POSPOM, CCI, intraoperative parameters like vitals, medication, estimated blood loss and postoperative data obtained from PACU records and discharge letter. Primary Endpoint are postoperative complications assessed with the Cavien-Dindo classification \> 2.

Interventions

None listed

Sponsors

Technical University of Munich
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* written informed consense * Age \> 18 years * ASA Score 3 or 4 * elective non-cardiac high risk surgery

Exclusion criteria

* emergency surgery * need for dialysis * liver cirrhosis child C * intolerance of albumin * participation in other AMG (medicines law) study * pregnancy or breastfeeding * patients with attendants concerning medical matters * ASA V patients * patients with BMI \> 35 kg/m2

Design outcomes

Primary

MeasureTime frameDescription
postoperative complications determined with the calvien-dindo classificationdate of surgery until hospital discharge (approx. 30 days)Pulmonary, infectious, renal, gastrointestinal, cardiovascular, neurological, wound, haematological and pain. Each domain is graded between grade I and V (death of a patient).

Secondary

MeasureTime frameDescription
hospital mortalitydate of surgery until hospital discharge (approx. 30 days)Rate of Mortality among study patients
Acute Kidney Injurypostoperative day 2Acute Kidney Injury according to KDIGO
Myocardial Injurypostoperative day 2perioperative hsTnT course, including preoperative hsTnT measurements
6 months mortalitiydate of surgery until 6 months afterRate of Mortality among study patients

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026